http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115073429-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4be11b11c9d11713e1cc3feb9163eff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8951a217e01b940379b20aedc2d693c9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C227-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-18
filingDate 2021-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_638a56560988cecea0ecc337c9bd7e92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e6f23fe5f8e9a16342302ab8e243e95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e6962c1511b5f6835d61f03b4af7fc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_965f2502563c2ead92021d483e245b4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9eeace9674f75eb0261e46a6b011fa96
publicationDate 2022-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-115073429-A
titleOfInvention A kind of salt form, crystal form and preparation method of 1,2,4-triazine-3,5-dione compound
abstract The invention discloses a salt form, a crystal form of a 1,2,4-triazine-3,5-dione (formula I) compound and a preparation method thereof, and its use in treatment and/or pharmaceutical preparation. The use described is in the treatment of diseases associated with thyroid hormone receptors.
priorityDate 2021-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420611345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8567
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16219760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407318370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59834482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5885
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454557040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22828848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448864225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533068
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457673815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506849

Total number of triples: 57.